OBJECTIVE: To identify and describe correlates of medication adherence in a large, national sample of outpatients with bipolar disorder. METHOD: Data were collected via a self-report, Web-based survey in January and February of 2008 from US patients aged 18-65 years who reported a diagnosis of bipolar disorder and current use of psychotropic medication. Patients with a Composite International Diagnostic Interview-bipolar disorder (CIDI-bipolar disorder) score ≥ 7, indicating a high risk of bipolar disorder, were included in the analyses. Medication adherence was assessed via the Morisky Medication Adherence Scale, with scores ≥ 2 being considered nonadherent. The primary analysis was a multivariate binomial logistic regression with adherence as the dependent variable. Covariates included patient demographics, physical health measures including Medical Outcomes Study 8-item Short-Form Health Survey physical summary score, number of manic and depressive episodes, 24-item Behavior and Symptom Identification Scale (BASIS-24), Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS), Satisfaction With Antipsychotic Medication scale (SWAM), and current psychiatric medication use. RESULTS: Nearly half (49.5%) of the 1,052 bipolar patients in the analysis were classified as being nonadherent. Adherence was positively associated with college degree, higher SWAM total score, and monotherapy treatment. Adherence was negatively associated with female sex, alcohol use, BASIS-24 total score, and LUNSERS total score. CONCLUSIONS: Nonadherence is common among patients with bipolar disorder. By addressing tolerability issues and treatment satisfaction, which are both significant correlates of adherence, health care providers may be able to improve adherence and, ultimately, treatment outcomes.
OBJECTIVE: To identify and describe correlates of medication adherence in a large, national sample of outpatients with bipolar disorder. METHOD: Data were collected via a self-report, Web-based survey in January and February of 2008 from US patients aged 18-65 years who reported a diagnosis of bipolar disorder and current use of psychotropic medication. Patients with a Composite International Diagnostic Interview-bipolar disorder (CIDI-bipolar disorder) score ≥ 7, indicating a high risk of bipolar disorder, were included in the analyses. Medication adherence was assessed via the Morisky Medication Adherence Scale, with scores ≥ 2 being considered nonadherent. The primary analysis was a multivariate binomial logistic regression with adherence as the dependent variable. Covariates included patient demographics, physical health measures including Medical Outcomes Study 8-item Short-Form Health Survey physical summary score, number of manic and depressive episodes, 24-item Behavior and Symptom Identification Scale (BASIS-24), Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS), Satisfaction With Antipsychotic Medication scale (SWAM), and current psychiatric medication use. RESULTS: Nearly half (49.5%) of the 1,052 bipolarpatients in the analysis were classified as being nonadherent. Adherence was positively associated with college degree, higher SWAM total score, and monotherapy treatment. Adherence was negatively associated with female sex, alcohol use, BASIS-24 total score, and LUNSERS total score. CONCLUSIONS: Nonadherence is common among patients with bipolar disorder. By addressing tolerability issues and treatment satisfaction, which are both significant correlates of adherence, health care providers may be able to improve adherence and, ultimately, treatment outcomes.
Authors: Joseph F Goldberg; John O Brooks; Keiko Kurita; Jennifer C Hoblyn; S Nassir Ghaemi; Roy H Perlis; David J Miklowitz; Terence A Ketter; Gary S Sachs; Michael E Thase Journal: J Clin Psychiatry Date: 2009-02-10 Impact factor: 4.384
Authors: Dawn I Velligan; Peter J Weiden; Martha Sajatovic; Jan Scott; Daniel Carpenter; Ruth Ross; John P Docherty Journal: J Clin Psychiatry Date: 2009 Impact factor: 4.384
Authors: Laurel A Copeland; John E Zeber; Ihsan M Salloum; Harold A Pincus; Michael J Fine; Amy M Kilbourne Journal: J Nerv Ment Dis Date: 2008-01 Impact factor: 2.254
Authors: Michael Bauer; Tasha Glenn; Paul Grof; Wendy Marsh; Kemal Sagduyu; Martin Alda; Greg Murray; Ute Lewitzka; Rita Schmid; Sara Haack; Peter C Whybrow Journal: Hum Psychopharmacol Date: 2010-01 Impact factor: 1.672
Authors: Vicki C Fung; Lindsay N Overhage; Louisa G Sylvia; Noreen A Reilly-Harrington; Masoud Kamali; Keming Gao; Richard C Shelton; Terence A Ketter; William V Bobo; Michael E Thase; Joseph R Calabrese; Mauricio Tohen; Thilo Deckersbach; Andrew A Nierenberg Journal: J Affect Disord Date: 2019-07-02 Impact factor: 4.839
Authors: Martha Sajatovic; Jennifer B Levin; Johnny Sams; Kristin A Cassidy; Kouri Akagi; Michelle E Aebi; Luis F Ramirez; Steven A Safren; Curtis Tatsuoka Journal: Bipolar Disord Date: 2015-09 Impact factor: 6.744
Authors: Lauren M Weinstock; Brandon A Gaudiano; Gary Epstein-Lubow; Katherine Tezanos; Cintly E Celis-Dehoyos; Ivan W Miller Journal: Psychiatry Res Date: 2014-02-01 Impact factor: 3.222
Authors: Jörn Conell; Rita Bauer; Tasha Glenn; Martin Alda; Raffaella Ardau; Bernhard T Baune; Michael Berk; Yuly Bersudsky; Amy Bilderbeck; Alberto Bocchetta; Letizia Bossini; Angela Marianne Paredes Castro; Eric Yat Wo Cheung; Caterina Chillotti; Sabine Choppin; Maria Del Zompo; Rodrigo Dias; Seetal Dodd; Anne Duffy; Bruno Etain; Andrea Fagiolini; Julie Garnham; John Geddes; Jonas Gildebro; Ana Gonzalez-Pinto; Guy M Goodwin; Paul Grof; Hirohiko Harima; Stefanie Hassel; Chantal Henry; Diego Hidalgo-Mazzei; Vaisnvy Kapur; Girish Kunigiri; Beny Lafer; Chun Lam; Erik Roj Larsen; Ute Lewitzka; Rasmus Licht; Anne Hvenegaard Lund; Blazej Misiak; Patryk Piotrowski; Scott Monteith; Rodrigo Munoz; Takako Nakanotani; René E Nielsen; Claire O'Donovan; Yasushi Okamura; Yamima Osher; Andreas Reif; Philipp Ritter; Janusz K Rybakowski; Kemal Sagduyu; Brett Sawchuk; Elon Schwartz; Ângela Miranda Scippa; Claire Slaney; Ahmad Hatim Sulaiman; Kirsi Suominen; Aleksandra Suwalska; Peter Tam; Yoshitaka Tatebayashi; Leonardo Tondo; Eduard Vieta; Maj Vinberg; Biju Viswanath; Julia Volkert; Mark Zetin; Iñaki Zorrilla; Peter C Whybrow; Michael Bauer Journal: Int J Bipolar Disord Date: 2016-08-24